Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 12 studies | 22% ± 4% | |
astrocyte | 10 studies | 34% ± 18% | |
endothelial cell | 6 studies | 22% ± 5% | |
glutamatergic neuron | 5 studies | 41% ± 19% | |
oligodendrocyte | 5 studies | 26% ± 8% | |
smooth muscle cell | 4 studies | 19% ± 3% | |
GABAergic neuron | 4 studies | 37% ± 11% | |
oligodendrocyte precursor cell | 4 studies | 35% ± 9% | |
epithelial cell | 3 studies | 34% ± 12% | |
ependymal cell | 3 studies | 36% ± 19% | |
adventitial cell | 3 studies | 21% ± 2% | |
neuron | 3 studies | 34% ± 14% | |
interneuron | 3 studies | 41% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 36% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5025.72 | 245 / 245 | 100% | 101.28 | 502 / 502 |
brain | 100% | 2883.58 | 2630 / 2642 | 100% | 41.74 | 703 / 705 |
breast | 99% | 3075.44 | 456 / 459 | 96% | 26.32 | 1076 / 1118 |
thymus | 96% | 1483.89 | 627 / 653 | 88% | 10.06 | 533 / 605 |
bladder | 100% | 4145.38 | 21 / 21 | 81% | 26.40 | 407 / 504 |
adrenal gland | 97% | 4048.18 | 250 / 258 | 79% | 14.74 | 182 / 230 |
stomach | 99% | 3795.80 | 355 / 359 | 70% | 14.15 | 199 / 286 |
kidney | 85% | 1020.10 | 76 / 89 | 81% | 9.76 | 727 / 901 |
intestine | 91% | 5943.20 | 882 / 966 | 75% | 13.81 | 393 / 527 |
lung | 98% | 3054.06 | 564 / 578 | 65% | 6.73 | 750 / 1155 |
skin | 89% | 1791.12 | 1606 / 1809 | 72% | 8.69 | 339 / 472 |
ovary | 99% | 3301.54 | 178 / 180 | 60% | 5.47 | 258 / 430 |
esophagus | 100% | 4319.29 | 1443 / 1445 | 55% | 5.75 | 101 / 183 |
uterus | 100% | 2586.17 | 170 / 170 | 49% | 7.33 | 227 / 459 |
pancreas | 42% | 374.63 | 138 / 328 | 92% | 12.17 | 163 / 178 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.69 | 1 / 1 |
blood vessel | 100% | 4052.09 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 3028.24 | 1175 / 1204 | 0% | 0 | 0 / 0 |
heart | 89% | 1868.18 | 769 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 61% | 7.18 | 49 / 80 |
muscle | 36% | 447.23 | 292 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 27% | 2.53 | 12 / 45 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.86 | 6 / 29 |
liver | 2% | 12.36 | 4 / 226 | 16% | 1.50 | 64 / 406 |
spleen | 10% | 90.56 | 25 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 55.69 | 56 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_1902554 | Cellular component | serine/threonine protein kinase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CAB39L |
Protein name | Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein) Calcium binding protein 39 like |
Synonyms | |
Description | FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1 (By similarity). . FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1. . FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1. . FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1. . FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1. . FUNCTION: Component of a complex that binds and activates STK11/LKB1. In the complex, required to stabilize the interaction between CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta) and STK11/LKB1. . |
Accessions | B7ZBJ5 ENST00000413278.5 B7ZBJ6 ENST00000610540.4 ENST00000409308.6 B7ZBJ4 ENST00000409130.5 Q9H9S4 Q5TAW7 ENST00000425242.5 ENST00000409082.5 B7ZBJ7 ENST00000410043.5 ENST00000457041.5 ENST00000347776.9 ENST00000355854.8 |